VM 55599: from Penicillium strain IMI 332995; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 196934 |
| MeSH ID | M0223439 |
| Synonym |
|---|
| vm 55599 |
| vm55599 |
| 148717-88-8 |
| 1h,5h-5a,12b-(iminoethano)pyrrolizino(1,2-b)carbazol-14-one, 2,3,6,11,12,12a-hexahydro-1,12,12-trimethyl-, (1r-(1alpha,5abeta,12abeta,12bbeta))- |
| 1,12,12-trimethyl-2,3,11,12,12a,13-hexahydro-1h,5h,6h-13a,5a-(azenometheno)indolizino[7,6-b]carbazol-15-ol |
| DTXSID20933467 |
| (13r,16s)-12,12,16-trimethyl-10,19,22-triazahexacyclo[13.5.2.01,13.03,11.04,9.015,19]docosa-3(11),4,6,8-tetraen-21-one |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.41) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (14.29%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (85.71%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||